Status:
UNKNOWN
Use of Lumella-glycosylated Fibronectin for Diagnosis of Preeclampsia
Lead Sponsor:
Croydon University Hospital
Conditions:
Preeclampsia
Pregnancy Related
Eligibility:
FEMALE
Brief Summary
women with symptoms of preeclampsia from antenatal clinic or triage will be offered Lumella test along with traditional blood tests. If Lumella test is positive which will be compared with the traditi...
Detailed Description
Pre-eclampsia is a potentially serious condition that affects pregnant women. It is usually diagnosed during routine antenatal appointments. This is based on blood pressure measurements and results of...
Eligibility Criteria
Inclusion
- If they can speak English
- Can give informed consent
- Has symptoms of Preeclampsia
Exclusion
- Can't speak English
- Does not want to participate
Key Trial Info
Start Date :
November 10 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 30 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06085001
Start Date
November 10 2023
End Date
August 30 2024
Last Update
October 16 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Croydon University Hospital
Croydon, Surrey, United Kingdom, CR7 7YE